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Abstract
Background
Personal cancer risk assessments enable stratified care, for example, offering preventive
surgical measures such as risk-reducing mastectomy (RRM) to women at high risk for
breast cancer. In scenario-based experiments, we investigated whether different benefit–
harm ratios of RRM influence women’s consideration of this, whether this consideration is
influenced by women’s perception of and desire to know their personal cancer risk, or by
their intention to take a novel cancer risk-predictive test, and whether consideration varies
across different countries.
Method
In January 2017, 1,675 women 40 to 75 years of age from five European countries—Czech
Republic, Germany, UK, Italy, and Sweden—took part in an online scenario-based experi-
ment. Six different scenarios of hypothetical benefit–harm ratios of RRM were presented in
accessible fact box formats: Baseline risk/risk reduction pairings were 20/16, 20/4, 10/8, 10/
2, 5/4, and 5/1 out of 1,000 women dying from breast cancer.
Results
Varying the baseline risk of dying from breast cancer and the extent of risk reduction influ-
enced the decision to consider RRM for 23% of women. Decisions varied by country, risk
perception, and the intention to take a cancer risk-predictive test. Women who expressed a
stronger intention to take such a test were more likely to consider having RRM. The desire
to know one’s risk of developing any female cancer in general moderated women’s deci-
sions, whereas the specific desire to know the risk of breast cancer did not.
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Conclusions
In this hypothetical scenario-based study, only for a minority of women did the change in
benefit–harm ratio inform their consideration of RRM. Because this consideration is influ-
enced by risk perception and the intention to learn one’s cancer risks via a cancer risk-pre-
dictive test, careful disclosure of different potential preventive measures and their benefit–
harm ratios is necessary before testing for individual risk. Furthermore, information on risk
testing should acknowledge country-specific sensitivities for benefit–harm ratios.
Introduction
Genetic, epigenetic, lifestyle, and reproductive factors alone or combined can be used to pre-
dict a woman’s risk for developing breast cancer.[1–3] Although the average 10-year absolute
risk of breast cancer in women in the UK aged 50 years is 2.85%, women at the lowest and
highest percentile of the risk distribution have a 0.53% and 9.96% 10-year risk, respectively.[4]
Risk prediction can be used in each of these cases to enable risk-stratified early detection and
risk-reducing preventive interventions.[5–7]
The FORECEE Consortium (Female Cancer Prediction Using Cervical Omics To Individu-
alise Screening And Prevention; https://forecee.eu) aims to develop a risk-predictive test—for
breast, cervical, endometrial, and ovarian cancer—in cervical epithelial cells, based on epige-
netic markers.[8] Once identified, women at high risk of breast cancer could be offered risk-
reducing surgery. Although there is no evidence from randomised clinical trials on the effec-
tiveness of risk-tailored preventive intervention at the population level, there are clinical guide-
lines that suggest the option of risk-reducing surgery, for example, for women with BRCA1 or
BRCA2 mutations.[9] Such interventions have both potential benefits and harms (e.g., psycho-
logical distress, complications from surgery).[10]
Among BRCA mutation carriers in Europe, more recent findings reveal proportions of
about 36% in the Netherlands[11] and 34% in Wales[12] who opted for a risk-reducing mas-
tectomy (RRM). Known factors that influence RRM decisions are having children, risk percep-
tion, cancer worry, and risk level.[13] What happens, however, if women misperceive the
numerical relationship between their individual cancer risk and the potential benefit from risk
reduction, as is the case for cancer screening?[14] Women who overestimate benefit–harm
ratios may more likely consider mastectomy.[15] This may be even more pronounced for
women who already have an elevated perception of their individual breast cancer risk.[16, 17]
Moreover, women who have a strong desire to know their cancer risks and who perceive being
in control of managing these risks[18] may also be more likely to control any elevated breast
cancer mortality risk effectively by preventive surgery.[19]
Presenting women with six different scenarios, we investigated in this experimental survey
study whether (1) varying baseline risks of breast cancer-specific mortality and varying extents
of reduction in breast cancer-specific mortality following mastectomy would affect women’s
consideration of RRM. In order to control whether aspects other than risk information would
moderate their decisions, we further investigate if potential differences in women’s consider-
ations are associated with (2) their perception of the individual female cancer risk, (3) their
desire to know their female cancer risks, and (4) their intention to take a novel risk-predictive
test if available. Finally, we investigated (5) whether the proportion of women considering
RRM varied across European countries.
A scenario-based experiment on the risk-dependent consideration of risk-reducing mastectomy
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Materials and methods
We developed an online survey questionnaire, which was translated into five languages.
FORECEE Consortium[8] members from each of the five countries checked for the correct-
ness and completeness of the translation. The survey was administered via e-mail by the mar-
ket research institute Harris Interactive (Germany) to a sample of the Harris Interactive Panel
and the Toluna Panel (sampling frame details in S1 Text).
The study was approved by the Institutional Ethics Board of the Max Planck Institute for
Human Development, Berlin (Germany). It was carried out in accordance with the guidelines
and regulations of the Max Planck Society for the Advancement of Science in Germany. Writ-
ten informed consent was required to participate in this particular study.
In January 2017, Harris Interactive drew national samples of women in the core age group
of screening programs and around that core age (aged 40 to 75 years) from five European
countries that represent Northern (Sweden), Eastern (Czech Republic), Southern (Italy), West-
ern (United Kingdom), and Central Europe (Germany): Of the 3,629 women invited (inclu-
sion criteria: aged 40 to 75 years), 2,092 responded and 1,675 completed the survey (response
rate: 61.4%). The questionnaire did not allow for item nonresponse. Sample selection and sam-
ple population are detailed elsewhere.[20]
Survey questionnaire
The survey consisted of three sections eliciting women’s disease risk perception, their attitude
toward cancer risk-predictive testing based on epigenetic markers, and their considerations to
undertake RRM. Participants were presented with a leaflet containing baseline risk informa-
tion about developing breast, cervical, endometrial, or ovarian cancer within 10 years and a
novel risk-predictive test (S1 Fig) before they were asked once more about their disease risk
perceptions. Subsequently, participants were presented with an introduction to six hypotheti-
cal scenarios that asked them to imagine having a higher-than-average risk of breast cancer
(S2 Fig). They were then presented with a fact box informing them about the fictitious effect of
having or not having RRM on breast cancer mortality risk (Fig 1). Fact boxes are tabular for-
mats that present information on the benefits and harms of a medical option for a control
group and an intervention group in absolute numbers, which are adjusted to the same denom-
inator.[21–23]
Within the fact box, in a frequency format,[24] information was provided on the potential
benefits and harms of RRM. Numbers characterising the benefit were varied experimentally:
The baseline risks of 10-year breast cancer-related mortality (defined interval instead of life-
time risk[25]) were varied from high to extremely high across the scenarios (20 vs. 10 vs. 5 out
of 1,000 women not having RRM). Following RRM, each breast cancer mortality risk was
reduced by 20% and 80% to represent limited risk reduction and realistic risk reduction,
respectively. None of these variations led any scenario to be more realistic than another from
the perspective of the participants. In fact, prophylactic mastectomy could reduce the risk of
developing breast cancer by about 90% to 95%[26] and breast cancer mortality by 80%.[27]
The fact box was presented together with the question “Would you consider having prophy-
lactic removal of your breasts?”. At the end of the survey, participants were debriefed that the
figures in the scenarios were hypothetical and how they were varied across the scenarios.
Analysis
Within-subjects and between-subjects analyses were performed using variance analyses, with
samples approximating normal distributions. Linear regressions with the dependent variable
average level of mastectomy consideration across the six scenarios and logistic regressions
A scenario-based experiment on the risk-dependent consideration of risk-reducing mastectomy
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with the dependent variable scenario-specific mastectomy consideration were conducted to
investigate the influences of disease risk perception, a general desire to know one’s female can-
cer risk, and the intention to have a risk-predictive test for female cancer. Different response
patterns of consideration were identified and the association with the study variables was
assessed using the Chi-squared test.
Results
Among the 1,675 women in the study (the participants characteristics are described in S1
Table), we identified three general response patterns (Table 1): 968 (58%) did not consider
mastectomy in any of the presented scenarios, 323 (19%) decided to consider mastectomy in
each of the six scenarios, and 384 (23%) women varied their responses across the scenarios.
Thus, only for the latter group does the numerical relationship between cancer risks and risk
reduction through RRM appear to have an effect on their decisions to consider mastectomy.
Notably, 112 out of 384 participants violated transitivity across scenarios at least once: 46 con-
sidered a mastectomy for reducing mortality risk from 20 to 12, but not for a reduction from
20 to 4 out of 1,000; 53 participants considered it for 10 to 6, but not for 10 to 2; and 41 partici-
pants considered it for 5 to 3, but not for 5 to 1.
The distribution of response patterns varied not with age, but with education (χ2(4) =
23.11, p< .001): Women with low levels of the International Standard Classification of Educa-
tion (ISCED) were more likely to consider mastectomy in every scenario, those with medium
levels were more likely to never consider mastectomy, and those with high levels were more
likely to consider mastectomy in dependence of the risk information provided in the scenarios.
Fig 1. Example of a fact box which provides women with information on the benefits and harms of having/not
having RRM. Note that although the information on the benefits was varied across scenarios, the information on
harms remained constant.
https://doi.org/10.1371/journal.pone.0218188.g001
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Response patterns varied by country (χ2(8) = 124.07, p< .001): 75.5% of women in Germany
but only 42.1% of women in the United Kingdom and 43.0% in Sweden never considered mas-
tectomy in the scenarios. Conversely, 24.8% of women in the United Kingdom and 27.6% in
Sweden, but only 9.3% of women in Germany, considered mastectomy in each scenario
(Table 1). Women reporting personal or familial cancer experience did not respond differently
Table 1. Response patterns to the scenarios stratified by factors.
Proportion: always no
(n = 968)
[%]
Proportion: scenario- dependent
(n = 384)
[%]
Proportion: always yes
(n = 323)
[%]
pa
Age [groups] .909
40–49 years 56.4 23.0 20.6
50–59 years 58.8 23.3 18.0
60–69 years 58.9 21.7 19.4
70–75 years 56.1 25.0 18.9
Education [ICED] < .001
High 50.6 30.0 19.3
Medium 62.7 19.8 17.5
Low 55.3 22.4 22.4
Personal female cancer history .041
Yes 48.1 23.1 28.8
No 58.6 23.0 18.4
Not known 48.0 20.0 32.0
Reporting personal or familial cancer history .672
Reporting 57.9 23.4 18.7
Not reporting 57.7 22.1 20.3
Country < .001
Czech Republic 61.8 22.8 15.4
Germany 75.5 15.2 9.3
UK 42.1 33.1 24.8
Italy 65.1 14.8 20.1
Sweden 43.0 29.4 27.6
Breast cancer risk perception .008
Increased 49.9 24.8 25.4
Correct 59.6 22.8 17.7
Decreased 60.4 21.8 17.8
Desire to know one’s female cancer risks < .001
All risks 51.5 25.7 22.8
Some risks 58.7 28.0 13.3
No risks 72.1 14.8 13.1
Desire to know one’s breast cancer risk
Yes 52.5 25.8 21.7 < .001
No 71.3 15.6 13.1
Intention to take a novel risk-predictive test < .001
Definitely DO 48.3 26.0 25.8
Probably DO 56.4 25.8 17.8
Probably NOT 69.7 15.3 15.0
Definitely NOT 76.8 10.7 12.5
aChi-squared tests
https://doi.org/10.1371/journal.pone.0218188.t001
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from women without this experience, but a higher proportion of women with personal female
cancer experience considered mastectomy across all scenarios.
Is the numerical relationship between breast cancer mortality risks and risk
reduction across the scenarios associated with the consideration of RRM?
Higher baseline risk of breast cancer mortality (F(2,3348) = 43.67, p< .001, ηp2 = 0.03) and
larger mortality risk reduction with RRM (F(1,1674) = 62.86, p< .001, ηp2 = 0.04) were associ-
ated with a larger average consideration of RRM in our sample (Fig 2). The effects remained
stable after excluding from the analysis women with female cancer history (n = 104), breast
cancer diagnosis, or ductal carcinoma in situ (n = 59). Including age group as a between-sub-
ject factor revealed neither a main effect on consideration (F(3,1671) = 0.25, p = .862) nor
interactions with baseline risk (F(6,3243) = 1.81, p = .095) or risk reduction (F((3,1671) = 2.19,
p = .087). Factors associated with scenario-dependent responses are presented in S2 Table.
Fig 2. Mastectomy considerations according to baseline mortality risks. The risk of dying from breast cancer and the level of risk reduction were varied across the
scenarios. Error bars show the standard error of the mean.
https://doi.org/10.1371/journal.pone.0218188.g002
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Does the consideration of RRM vary across European countries?
The decisions on considering RRM were influenced by multiple factors, including country,
level of education, personal female cancer history, breast cancer risk perception after reading
an information leaflet, desire to know one’s female cancer risks, desire to know one’s breast
cancer risk, and intention to take a novel risk-predictive test (Table 2).
As the response patterns indicated, women’s decisions varied across countries. For each
scenario, women from the United Kingdom and Sweden were most likely to consider having
RRM, whereas women from Germany were least likely to consider having it (Fig 3).
Table 2. Average mastectomy consideration stratified by factors.
n Average mastectomy consideration M(SD) F p ηp2 a
Age [groups] F(3, 1671) = 0.25 .862 –
40–49 years 495 0.31 (0.41)
50–59 years 490 0.29 (0.40)
60–69 years 494 0.29 (0.41)
70–75 years 196 0.30 (0.40)
Education [ICED] F(2, 1672) = 5.37 .005 0.01
High 393 0.33 (0.41)
Medium 817 0.27 (0.40)
Low 465 0.30 (0.41)
Personal female cancer history F(2, 1672) = 4.49 .011 0.01
Yes 104 0.40 (0.45)
No 1,546 0.29 (0.40)
Not known 25 0.43 (0.47)
Country F(4, 1670) = 27.58 < .001 0.06
Czech Republic 356 0.25 (0.38)
Germany 335 0.16 (0.32)
UK 323 0.42 (0.43)
Italy 338 0.27 (0.41)
Sweden 323 0.42 (0.43)
Breast cancer risk perception F(2, 1672) = 8.78 < .001 0.01
Increased 343 0.38 (0.44)
Correct 905 0.28 (0.40)
Decreased 427 0.28 (0.40)
Desire to know one’s female cancer risks F(2, 1672) = 28.03 < .001 0.03
All risks 1,066 0.36 (0.42)
Some risks 150 0.24 (0.37)
No risks 459 0.19 (0.36)
Desire to know one’s breast cancer risk F(1, 1673) = 45.18 < .001 0.03
Yes 1,201 0.34 (0.36)
No 474 0.19 (0.36)
Intention to take a novel risk-predictive test F(3, 1671) = 18.17 < .001 0.03
Definitely DO 497 0.39 (0.44)
Probably DO 759 0.30 (0.40)
Probably NOT 307 0.21 (0.37)
Definitely NOT 112 0.16 (0.34)
a ηp
2 (Partial eta square) reflects the ratio of variance associated with an effect to the sum of this variance plus associated error variance.
https://doi.org/10.1371/journal.pone.0218188.t002
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A stepwise regression showed that country-specific considerations of mastectomy were
moderated by the general desire to know one’s female cancer risks (F(8, 1666) = 34.22, p<
.001, R2 = 0.10) (Fig 4). The general desire to know (β = .22, p< .001) explained the increased
consideration of mastectomy across countries. However, women from Italy (β = -0.18, p<
.001), Germany (β = -0.09, p = .026), and the Czech Republic (β = -0.16, p< .001) with a gen-
eral desire to know their female cancer risks were less likely to consider mastectomy than
those from the United Kingdom. Moreover, German women (β = -.13, p< .001) were less
likely to consider mastectomy in general (Fig 4).
Does an increased risk perception of disease influence consideration?
During the study, the women were given a leaflet containing the age-specific risks of develop-
ing breast cancer.[20] After reading it, they were asked to indicate an estimate of their personal
Fig 3. European mastectomy considerations according to baseline mortality risks. Proportion of women considering RRM by country and baseline risk of
breast cancer-specific mortality. Error bars show the standard error of the mean.
https://doi.org/10.1371/journal.pone.0218188.g003
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breast cancer risk. The proportion of women who estimated having an increased risk of breast
cancer was 20.5%. Women who perceived themselves to be at higher risk considered RRM
more often (averaged across the scenarios M = 0.38, SD = 0.44). In comparison, the average
consideration of those who did not perceive themselves to be at higher risk was M = 0.28
(SD = 0.40). This association holds after controlling for several factors, including the desire to
know one’s risk level and the intention to take a novel risk-predictive test under development.
Is women’s intention to take a novel cancer risk-predictive test associated
with their consideration of RRM?
The stepwise regression showed that the women were more likely to decide to consider mas-
tectomy when they intended to take the predictive test for four different types of cancer and
when they had a general desire to know their cancer risk, averaged across the four types of can-
cer. At the same time, when controlled for the general desire to know, the desire to know one’s
Fig 4. Mastectomy considerations according to country and general desire to know one’s cancer risks. Proportion of women considering RRM by country and
the amount of cancer risk information desired. Error bars show the standard error of the mean.
https://doi.org/10.1371/journal.pone.0218188.g004
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breast cancer risk did not make it more likely to consider mastectomy (Table 3). As women’s
disease risk perception may have interfered with their perceptions of the given mortality risks
across the scenarios, it is noteworthy that the described effect of the general desire to know
held even when controlled for disease risk perception.
To summarise and structure all described relationships, S3 Table classifies participants
according to a pipeline of their perception of breast cancer risk, their desire to know their
female cancer risks, and their intention to take a novel risk-predictive test which is under
development.
Discussion
Only 23% of the participants varied their decisions on RRM according to a given baseline risk
of breast cancer mortality and the expected risk reduction due to the mastectomy. In contrast,
most of the women always applied the same response strategy, that is, always responded “yes”
or “no” regardless of information provided. Although this phenomenon may hint to the fact
that the presented scenarios did not translate well to the women in our study, it is worth noting
that the consistent response patterns systematically varied across the five European countries.
For instance, we saw the largest proportion of women who would not consider undergoing
RRM in Germany and the largest proportion who would always consider it in the United
Kingdom and Sweden. Thus, the proportion of consistent response patterns observed in our
survey might be less an artefact of women not understanding the information provided than a
general national attitude toward having preventive surgeries to reduce cancer risk. The
observed variations in our study are indeed quite in line with real uptake rates in different
Table 3. Country-specific linear regressions of average consideration of RRM.
Standardised coefficient [95% Confidence interval] (p)
Czech Republic Germany United Kingdom Italy Sweden All countries
Risk perception of BC (increased estimation after reading information
leaflet)a
0.07
[-0.02,0.17]
(.184)
-0.05
[-0.15,0.05]
(.386)
0.22
[0.11,0.34]
(.001)
0.09
[-0.01,0.20]
(.092)
0.07
[-0.05,0.18]
(.242)
0.10
[0.05,0.15]
(< .001)
Desire to know one’s breastcancer risk a 0.09
[0.00,0.17]
(.114)
0.17
[0.10,0.24]
(.002)
0.16
[0.05,0.27]
(.005)
0.04
[-0.07,0.16]
(.430)
0.22
[0.11,0.33]
(< .001)
0.16
[0.11,0.20]
(< .001)
b 0.08
[-0.18,0.35]
(.641)
-0.05
[-0.27,0.17]
(.767)
-0.26
[-0.58,0.07]
(.118)
-0.07
[-0.43,0.30]
(.696)
-0.09
[-0.42,0.23]
(.568)
-0.09
[-0.22, 0.05]
(.248)
General desire to know one’s cancer risks a 0.08
[-0.01,0.17]
(.131)
0.19
[0.12,0.26]
(.001)
0.20
[0.09,0.31]
(< .001)
0.05
[-0.07,0.17]
(.333)
0.24
[0.13,0.35]
(< .001)
0.18
[0.13,0.23]
(< .001)
c 0.08
[-0.01,0.17]
(.142)
0.19
[0.07,0.31]
(.001)
0.20
[0.09,0.31]
(< .001)
0.06
[-0.06,0.19]
(.304)
0.24
[0.12,0.35]
(< .001)
0.17
[0.13,0.22]
(< .001)
Intention to have a novel risk-predictive test a 0.03
[-0.02,0.07]
(.567)
0.20
[0.17,0.24]
(< .001)
0.21
[0.16,0.27]
(< .001)
0.12
[0.07,0.18]
(.025)
0.19
[0.14,0.25]
(< .001)
0.17
[0.15,0.20]
(< .001)
c 0.03
[-0.02,0.07]
(.621)
0.21
[0.17,0.25]
(< .001)
0.21
[0.16,0.26]
(< .001)
0.13
[0.07,0.20]
(.019)
0.19
[0.13,0.25]
(.001)
0.17
[0.15,0.19]
(< .001)
aAdjusted for age, education, female cancer experience
bIf additionally adjusted for general desire to know one’s cancer risk
cIf additionally adjusted for BC risk perception.
https://doi.org/10.1371/journal.pone.0218188.t003
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countries.[28] In Wales (UK), 34% of all BRCA mutation carriers identified up to 2015 under-
went RRM[12], and 40% of participants opted for bilateral RRM in a study in England.[29] US
data similarly indicate increasing acceptance of this preventive measure.[30] A study from the
Netherlands shows that 36% of BRCA mutation carriers chose to undergo RRM within five
years after disclosure of the test result.[11]
A history of large-scale prevention campaigning in the United Kingdom and Sweden[31]
(with 42% of participants in each country considering RRM) could have promoted acceptance
of preventive measures in a larger proportion of the population than within the health systems
of the Czech Republic and Italy (with around 26% of participants in each country considering
RRM). The low proportion of women (16%) considering RRM in Germany, on the other
hand, could be due to media reporting on potential harms or shortcomings of personalized
medicine, whereas in the UK media, the potential merits are emphasized.[32] Moreover, high-
quality medical service is easily accessible in Germany even for people with low incomes (9 out
of 10 people in Germany have a statutory health insurance). One can speculate that particularly
women in Germany expect easy access to alternative preventive measures. Future research
thus needs to compare breast cancer prevention across different countries with different
healthcare systems.
Importantly, breast cancer risk perception, after reading an information leaflet on age-spe-
cific breast cancer disease risk, influenced the consideration of RRM, although the scenarios
presented numbers on the risk of breast cancer mortality. Those who perceived themselves to
be at higher risk of developing the disease were more likely to consider having mastectomy,
even if after having available information about “their” breast cancer mortality risk. Providing
this subgroup with particular care accompanied by evidence-based and consistent information
at all stages thus appears crucial for ensuring informed decision-making.
The desire to know one’s breast cancer risk was not associated specifically with considering
mastectomy in our study, whereas a general desire to know one’s risk of developing the four
different female cancers and the intention to take an offered cancer risk-predictive test (even
though it is still under development) were associated with considering. Many preventive con-
siderations regarding breast cancer are not necessarily based on disease-related interest.
Instead, it cannot be excluded that offering the test could nudge some part of the general popu-
lation toward surgery by advancing cancer risk-testing opportunities in the first place.
The hypothetical scenario-based approach does not allow for a direct transfer of our find-
ings to real-world health considerations. For instance, there is a gap between considering and
having prophylactic mastectomy.[33] Furthermore, benefits and harms of RRM were selective
and its effectiveness was varied. For example, to keep our experimental stimuli comprehensi-
ble, we did not include numbers for potential distress by having RRM. Instead, we expected
that participants themselves would most likely anticipate potential distress of breast removal.
It remains a limitation that we did not inquire about their feelings and perceived distress as
this presumably factors in considering RRM.
Participants could only marginally experience the decision faced by a high-risk woman.
However, we chose to use very high risks so that participants would not underestimate the
impact of potential real-world risks. A limitation of the study is that only breast cancer mortal-
ity risk is considered and not the risk of developing breast cancer. Another limitation is that
the presentation of the scenarios was in random sequence and non-adaptive, which can pro-
duce errors if participants are forced to make repeated judgments. This may have led the 112
participants (6.7%) to produce intransitive considerations. This is not surprising because low-
numerate people have difficulties in understanding numerical risk information, but this could
be overcome with the help of icon arrays in future studies.[34]
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With a 61% response rate, there is a potential participation bias and nonresponse bias. How-
ever, there is unlikely to be bias by disease experience. For example, 3.5% of participants from Ger-
many with a median age of 56 years reported a breast cancer diagnosis in the past. The cumulative
risks of developing breast cancer in Germany for women aged 54 and 59 years are 2.9% and 4.1%,
respectively.[35] Furthermore, our findings did not vary by including and excluding women who
reported a personal history of female or breast cancer in our study. Generally, the potential for a
selection bias by paid panellists as a sample is a qualitative limitation inherent to this type of online
survey. To surmount such a limitation, future research should use computer-assisted telephone
surveys with random digit dialling and representative cell-phone number shares.
How information is provided to the public is crucial. Obviously, many women in our study
did not take the presented cancer mortality baseline risk into account and the extent of mortal-
ity reduction, but were influenced by other factors. It follows that, if risk-predictive tests for
female cancers enter the healthcare system providing women with consistent evidence-based
health information at all different stages of their care, this will be particularly important in
order to ensure informed decisions. Furthermore, communication regarding cancer risk-pre-
dictive tests needs to promote reflection on potential benefits and harms of testing and non-
testing as well as on risk management in the first place. Finally, communication strategies
should also acknowledge country-specific health values.
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